These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4630169)

  • 1. The use of a range expander in automated anti-D quantitation.
    Cotton R; Sobey DF
    Vox Sang; 1973 Feb; 24(2):181-6. PubMed ID: 4630169
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of the single-channel autoanalyzer in the quantitation of anti-Rh-o.
    Sturgeon P; Kaye B
    Vox Sang; 1970 Jul; 19(1):14-33. PubMed ID: 4992288
    [No Abstract]   [Full Text] [Related]  

  • 3. Maternal serum and amniotic fluid Rh-D antibody levels in erythroblastosis fetalis.
    Lappin TR
    Vox Sang; 1971 Jul; 21(1):37-44. PubMed ID: 5000955
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody protein levels in the maternal serum in rhesus iso-immunization.
    Fraser ID; Tovey GH; Lockyer WJ; Sobey DF
    J Obstet Gynaecol Br Commonw; 1972 Dec; 79(12):1074-9. PubMed ID: 4630429
    [No Abstract]   [Full Text] [Related]  

  • 5. Automation in the blood transfusion laboratory: I. Antibody dectection and quantitation in the technicon autoanalyzer.
    Moore BP
    Can Med Assoc J; 1969 Feb; 100(8):381-7. PubMed ID: 4974689
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amniocentesis in Rh isoimmunization and the permeation of the fetal red blood cells to the mother].
    Frankowska K; Trzaska H; Lozińska D; Frasunkiewicz T
    Ginekol Pol; 1974 Jul; 45(7):863-9. PubMed ID: 4212540
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid clearance of Rh positive blood during experimental Rh immunisation.
    Woodrow JC; Finn R; Krevans JR
    Vox Sang; 1969 Nov; 17(5):349-61. PubMed ID: 4188198
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of maternal anti-D concentration in predicting the outcome of Rh(D) haemolytic disease.
    Harrison KL; Baker JW; Popper EI; Harden PA
    Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):6-8. PubMed ID: 6430264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-Rh immunoglobulin (D) subclasses and hemolytic disease of the newborn].
    Cregut R; Pinon F; Brossard Y
    Nouv Presse Med; 1973 Jul; 2(29):1947. PubMed ID: 4198948
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the serological diagnosis of ABO erythroblastosis].
    Bube FW
    Z Kinderheilkd; 1966 Feb; 95(3):231-6. PubMed ID: 4965215
    [No Abstract]   [Full Text] [Related]  

  • 11. Automated red cell antibody analysis. A parallel study. II. Identification of serological specificity.
    Perrault R; Högman C
    Vox Sang; 1971 Apr; 20(4):356-70. PubMed ID: 4999319
    [No Abstract]   [Full Text] [Related]  

  • 12. [Organization of the early diagnosis of hemolytic disease of the newborn at the District Institute for Blood Banking in Leipzig].
    Thierbach V; Berge H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):353-8. PubMed ID: 4193013
    [No Abstract]   [Full Text] [Related]  

  • 13. Rh prophylactic treatment during pregnancy. An attempt to select for treatment those at possible risk.
    Pollock J; Lewis M; Kaita H; Chown B; Bowman JM
    Vox Sang; 1974; 26(1):26-33. PubMed ID: 4214337
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of fetal hemolytic disease in Rh incompatibility].
    Zakut H; Mashiach S; Ben-David A
    Harefuah; 1972 Aug; 83(3):97-9. PubMed ID: 4629641
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of anti-Rh antibodies in the amniotic fluid.
    Biermè S; Marty Y; de Boissezon JF; Ducos J
    Ann Ostet Ginecol Med Perinat; 1970 Aug-1971 Aug; 92(8):527-8. PubMed ID: 5001774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of anti-Rh antibodies in amniotic fluid].
    Benoit P; Gagnon M; Doray BH; Bonin A; Bertrand R
    Union Med Can; 1972 Jan; 101(1):58-64. PubMed ID: 4622396
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of discriminant analysis in relating maternal anti-D levels to the severity of haemolytic disease of the Newborn.
    Morley G; Gibson M; Eltringham D
    Vox Sang; 1977; 32(2):90-8. PubMed ID: 403679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fluorimetric enzyme-linked immunoassay (FEIA) for measurement of anti-D antibodies.
    Parinaud J; Blanc M; Fournié A; Biermé S; Grandjean H
    Nouv Rev Fr Hematol (1978); 1984; 26(5):299-302. PubMed ID: 6438605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haemolytic disease of the newborn (fetus) (author's transl)].
    Fischer K; Poschmann A
    Immun Infekt; 1976 Dec; 4(6):249-60. PubMed ID: 828142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.